Hims & Hers Health (HIMS) reported Q3 earnings late Monday of $0.32 per diluted share, swinging from a loss of $0.04 a year earlier.

Analysts polled by Capital IQ expected EPS of $0.05.

Revenue in the quarter ended Sept. 30 was $401.6 million, up from $226.7 million a year earlier.

Analysts surveyed by Capital IQ expected $382.8 million.

The company expects Q4 revenue of between $465 million and $470 million. Analysts expect $421.1 million.

For full-year 2024, it now expects revenue between $1.46 billion and $1.47 billion. The company was previously looking at full-year revenue of $1.37 billion to $1.40 billion. Analysts expect $1.4 billion.

Price: 20.50, Change: +0.14, Percent Change: +0.69